Pearl River Capital, LLC Catalent, Inc. Transaction History

Pearl River Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$72.36 - $113.1 $242,840 - $379,563	3,356 New	3,356 $243,000
Q1 2022 May 13, 2022	SELL	$94.19 - $124.49 $1.06 Million - $1.41 Million	-11,301 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$119.57 - $139.07 $1.11 Million - $1.29 Million	9,256 Added 452.62%	11,301 $1.45 Million
Q3 2021 Nov 12, 2021	BUY	$109.17 - $142.35 $223,252 - $291,105	2,045 New	2,045 $272,000
Q4 2019 Feb 12, 2020	SELL	$47.06 - $56.64 $81,131 - $97,647	-1,724 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$47.45 - $58.05 $81,803 - $100,078	1,724 New	1,724 $82,000
Q1 2019 May 02, 2019	SELL	$29.84 - $43.92 $11,458 - $16,865	-384 Closed	0 $0
Q4 2018 Feb 08, 2019	BUY	$29.95 - $46.34 $11,500 - $17,794	384 New	384 $12,000

484

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pearl River Capital, LLC with notifications on news.